We are live on
!
Find out more
RJA
Raymond James & Associates Portfolio holdings
AUM
$164B
1-Year Est. Return
33.91%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
(+7.7%)
Cap. Flow
+$2.23B
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$520M |
| 2 |
UnitedHealth
UNH
|
+$332M |
| 3 |
Analog Devices
ADI
|
+$320M |
| 4 |
Fidelity National Information Services
FIS
|
+$265M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$516M |
| 2 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$512M |
| 3 |
Cisco
CSCO
|
+$348M |
| 4 |
Apple
AAPL
|
+$162M |
| 5 |
Devon Energy
DVN
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Financials | 8.92% |
| 3 | Healthcare | 7.98% |
| 4 | Industrials | 6.57% |
| 5 | Consumer Discretionary | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Advance Auto Parts
AAP
$3.35B
| $4.15M | ﹤0.01% |
106,475
+11,169
| +12% | +$592K |
|
1777
BioMarin Pharmaceuticals
BMRN
$11.6B
| $4.14M | ﹤0.01% |
58,892
-3,992
| -6% | -$334K |
|
1778
Genmab
GMAB
$17.7B
| $4.14M | ﹤0.01% |
169,747
+3,598
| +2% | +$96.2K |
|
1779
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $4.14M | ﹤0.01% |
43,303
-733
| -2% | -$68.8K |
|
|
GUG
1780
Guggenheim Active Allocation Fund
GUG
$510M
| $4.13M | ﹤0.01% |
249,825
+81,042
| +48% | +$1.28M |
|
1781
Madrigal Pharmaceuticals
MDGL
$10.8B
| $4.12M | ﹤0.01% |
19,433
-888
| -4% | -$227K |
|
1782
Healthcare Services Group
HCSG
$1.6B
| $4.12M | ﹤0.01% |
369,137
-14,727
| -4% | -$162K |
|
1783
Oscar Health
OSCR
$9.41B
| $4.12M | ﹤0.01% |
194,300
-5,949
| -3% | -$107K |
|
1784
Innovator US Equity Ultra Buffer ETF August
UAUG
$163M
| $4.12M | ﹤0.01% |
117,536
-1,491
| -1% | -$50.8K |
|
1785
Kemper
KMPR
$1.67B
| $4.1M | ﹤0.01% |
66,951
-8,954
| -12% | -$551K |
|
1786
Modine Manufacturing
MOD
$10.7B
| $4.09M | ﹤0.01% |
30,812
+4,206
| +16% | +$465K |
|
1787
Green Brick Partners
GRBK
$3.04B
| $4.09M | ﹤0.01% |
48,965
+15,780
| +48% | +$1.14M |
|
1788
Reaves Utility Income Fund
UTG
$3.54B
| $4.07M | ﹤0.01% |
124,194
-177,535
| -59% | -$5.23M |
|
1789
Capital Group Municipal Income ETF
CGMU
$6.36B
| $4.07M | ﹤0.01% |
148,174
+24,598
| +20% | +$671K |
|
1790
UMB Financial
UMBF
$11.1B
| $4.06M | ﹤0.01% |
38,637
+26,186
| +210% | +$2.55M |
|
1791
Mach Natural Resources
MNR
$2.28B
| $4.06M | ﹤0.01% |
253,511
+123,790
| +95% | +$2.3M |
|
1792
DoubleLine Commercial Real Estate Debt ETF
DCRE
$459M
| $4.05M | ﹤0.01% |
77,893
-8,423
| -10% | -$435K |
|
1793
Valmont Industries
VMI
$9.3B
| $4.04M | ﹤0.01% |
13,934
+407
| +3% | +$114K |
|
1794
Zions Bancorporation
ZION
$10.2B
| $4.03M | ﹤0.01% |
85,285
+33,587
| +65% | +$1.59M |
|
1795
Invesco Variable Rate Investment Grade ETF
VRIG
$1.8B
| $4.03M | ﹤0.01% |
160,470
+76,086
| +90% | +$1.91M |
|
1796
JFrog
FROG
$9.66B
| $4.02M | ﹤0.01% |
138,568
-29,758
| -18% | -$935K |
|
1797
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
| $4.02M | ﹤0.01% |
156,094
+2,982
| +2% | +$75.4K |
|
|
BSJP
1798
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $4.02M | ﹤0.01% |
173,796
-36,302
| -17% | -$837K |
|
1799
UGI
UGI
$7.74B
| $4.01M | ﹤0.01% |
160,451
+15,527
| +11% | +$374K |
|
1800
Franklin US Low Volatility High Dividend Index ETF
LVHD
$628M
| $4.01M | ﹤0.01% |
98,576
+935
| +1% | +$36.1K |
|
Similar funds
RJFSA
PI
ECU
EAM
AA
SA
WPL
ECU
Raymond James & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
- Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
- Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
- Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
- Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
- Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
- Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.